PCHM — PharmChem Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSuper Stock

Annual cashflow statement for PharmChem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2002 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	PRESS	PRESS
Standards:	USG	USG	USG	—	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3.34	1.85	0.87	0.845	1.38
Depreciation
Deferred Taxes
Non-Cash Items	-4.35	-0.123	0.116	0.09	-0.163
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.091	-0.687	0.143	-0.278	0.066
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	1.34	0.875	1.27	0.639	1.31
Capital Expenditures	-1.42	—	—	—	—
Purchase of Fixed Assets
Other Investing Cash Flow Items	9.96	0.02	0	0	-0.003
Sale of Business
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities	8.54	0.02	0	0	-0.003
Financing Cash Flow Items	-1.99	—	—	—	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5.87	-6.51	-0.2	-2.35	-1.25
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4.02	-5.62	1.07	-1.71	0.057